---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-062257"
form_type: "8-K"
ticker: "FLGT"
cik: "0001674930"
company_name: "Fulgent Genetics, Inc."
filed_at: "2025-05-02T23:59:59+00:00"
generated_at: "2026-05-22T22:52:32.369859+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Fulgent Q1 core revenue $73.5M (+16% YoY); GAAP loss $0.37/share; reiterates FY25 guidance

## Summary
- Core revenue of $73.5M, up 16% YoY; GAAP net loss of $11.5M ($0.37 loss per share).
- Non-GAAP income of $1.2M ($0.04 per share); Adjusted EBITDA loss of $2.9M.
- Reiterates full-year 2025 core revenue guidance of $310M.
- Cash and investments $814.6M ($26.60 per share); repurchased ~516k shares for $8.7M in Q1.

## SEC filing metadata
- accession: 0000950170-25-062257
- form_type: 8-K
- ticker: FLGT
- cik: 0001674930
- company_name: Fulgent Genetics, Inc.
- filed_at: 2025-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674930/000095017025062257/0000950170-25-062257-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674930/000095017025062257/flgt-20250502.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-062257
- JSON: https://secwatch.observer/filing/0000950170-25-062257.json
- Plain text: https://secwatch.observer/filing/0000950170-25-062257.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.